Insider Trading & Ownership - Alam Kamran

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Alam Kamran
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-24
Sale
2023-08-25
4:30 pm
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
33,000$2.33$76,890258,042
(Direct)
View
2022-08-23
Sale
2022-08-24
4:47 pm
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
3,325$3.47$11,538266,121
(Direct)
View
2022-08-18
Sale
2022-08-22
8:05 pm
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
28,675$3.6966$105,999269,446
(Direct)
View
2021-08-18
Sale
2021-08-20
5:52 pm
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
33,000$16.88$557,023298,121
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-02
Tax Withholding
2024-02-06
4:42 pm
N/A
N/A
Taysha Gene Therapies Inc.TSHAAlam Kamran
CHIEF FINANCIAL OFFICER
1,288$1.51840,937
(Direct)
View
2024-01-02
Option Award
2024-01-04
4:43 pm
N/A
2034-01-02
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
590,413$01,432,638
(Direct)
View
2023-12-14
Option Award
2023-12-18
4:50 pm
N/A
2033-12-14
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
187,582$0187,582
(Direct)
View
2023-05-31
Option Award
2023-06-02
4:12 pm
N/A
N/A
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
6,230$0291,042
(Direct)
View
2023-02-02
Option Award
2023-02-06
9:12 pm
N/A
2033-02-02
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
205,975$0472,096
(Direct)
View
2022-04-06
Option Award
2022-04-08
4:27 pm
N/A
2032-04-06
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
40,000$040,000
(Direct)
View
2022-02-23
Option Award
2022-02-25
4:18 pm
N/A
2032-02-23
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
80,000$080,000
(Direct)
View
2021-01-19
Option Award
2021-01-20
8:20 pm
N/A
2031-01-19
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
70,000$070,000
(Direct)
View
2020-09-23
Option Award
2020-09-25
5:08 pm
N/A
N/A
Taysha Gene Therapies Inc.TSHAAlam Kamran
Chief Financial Officer
331,121$0331,121
(Direct)
View
2020-02-06
Option Award
2020-02-10
5:05 pm
N/A
2030-02-06
ROCKET PHARMACEUTICALS INC.RCKTAlam Kamran
SVP - Finance & PFO
28,000$028,000
(Direct)
View